BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04875195-completion@plaintrial.com
DTSTAMP:20261028T061756Z
DTSTART;VALUE=DATE:20251013
SUMMARY:A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classi
 cal Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastin
 al Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68) — estimated completion 
 date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT04875195
URL:https://plaintrial.com/trial/NCT04875195
END:VEVENT
END:VCALENDAR